Test Price
3,600 AED✅ Home Collection Available
Microarray 750K+ Single Karyotyping in UAE | AED 3,600 | DHA Licensed Genetic Diagnostic Test
Executive Summary & Core Metrics
Executive Summary: This clinically validated chromosomal microarray test delivers ≥99.9% diagnostic sensitivity for detecting copy number variations (CNVs) and loss of heterozygosity (LOH) across the genome, using >750,000 SNP markers on the Affymetrix CytoScan platform. With ISO 9001:2015-certified processing and strict hospital-only extraction for invasive prenatal specimens, sample integrity is maintained throughout the workflow. Post-test, a UAE-licensed Consultant Medical Geneticist provides telephonic clinical guidance. Direct insurance billing verification is available via WhatsApp at +971 54 548 8731.
- Accuracy Guarantee: ≥99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Collection Protocol: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance from a Consultant Medical Geneticist for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced genomic test screens fetal, neonatal, or product‑of‑conception samples for submicroscopic chromosomal imbalances that standard karyotyping cannot detect. It empowers gynecologists, clinical geneticists, and maternal‑fetal medicine specialists to make informed reproductive decisions. The platform detects pathogenic copy number changes as small as 50 kilobases and identifies regions of homozygosity that may indicate uniparental disomy or consanguinity.
| Feature | Our Test | Standard Karyotyping |
|---|---|---|
| Precision | >750K genome-wide SNP markers; detects CNVs >50 kb and LOH | ~5–10 Mb resolution; cannot detect microdeletions/duplications |
| Methodology | Affymetrix CytoScan 750K Array + Cell Culture | G‑banded karyotype (microscopy) |
| Turnaround Time | 7–9 Business Days | 10–14 Business Days |
Physician Insight & Safety Protocols
Ms. Lina Osama Zaki Quteineh (Consultant Medical Genetics | DHA Registration ID: 9294403) advises: “Chromosomal microarray provides unparalleled resolution for detecting pathogenic copy number variants linked to neurodevelopmental disorders, congenital anomalies, and pregnancy loss. However, results must always be interpreted in the context of family history, ultrasound findings, and clinical phenotype. A normal result does not exclude all genetic conditions, and variant-of-unknown-significance findings warrant careful genetic counseling. I strongly recommend pre-test counseling to discuss the scope and limitations of this assay.”
⚠ Medication Advisory
Do not discontinue any prescribed medication or supplement without consulting your doctor. If you are pregnant or undergoing fertility treatment, consult your obstetrician before making any changes to your regimen. Anticoagulant therapy may require temporary adjustment prior to invasive sampling; this must be coordinated with your prescribing physician.
Patient Safety & Exclusion Criteria
- Do not undergo this test if you have a severe coagulation disorder or are actively bleeding from the collection site (unless medically supervised).
- For amniotic fluid, CVS, or cord blood sampling, the procedure must be performed by a certified maternal‑fetal medicine specialist in a sterile hospital environment.
- Refrain from taking immunomodulatory drugs or anticoagulants 48 hours before sample collection, as advised by your physician.
- Emergency Red Flags: Seek immediate medical attention if you experience fever, severe abdominal pain, heavy vaginal bleeding, or signs of infection after an invasive sampling procedure.
Patient FAQ & Clinical Guidance
1. What is the detection rate of the 750K microarray for microdeletion syndromes?
The 750K‑resolution SNP array identifies pathogenic copy number changes with >99% sensitivity for known microdeletion syndromes, including those as small as 50 kilobases, surpassing traditional karyotyping which commonly misses submicroscopic anomalies. This high resolution enables the detection of clinically significant imbalances that would otherwise remain unidentified.
2. Can this test be performed on products of conception after a miscarriage?
Yes, the microarray can be performed on chorionic villi or formalin‑fixed paraffin‑embedded tissue from products of conception, providing a conclusive genetic diagnosis in over 90% of early pregnancy losses and guiding recurrence risk counseling. This approach often yields results when traditional karyotyping fails due to culture failure or maternal cell contamination.
3. Is a doctor’s prescription mandatory, and can I use insurance?
A valid physician’s prescription is required for all genetic microarray testing. Most UAE insurers cover this test when medically indicated for prenatal diagnosis, neurodevelopmental assessment, or recurrent pregnancy loss evaluation. We handle direct billing after WhatsApp verification at +971 54 548 8731. Pre-authorization may be required depending on your insurance plan.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Health Information Governance
DNA Labs UAE operates under the regulatory oversight of the Dubai Health Authority (DHA) and adheres to the following data protection frameworks:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): Ensures that all patient genetic and clinical data are processed lawfully, collected for specified purposes, and stored with appropriate technical and organizational safeguards.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Governs the electronic handling of health records, telemedicine consultations, and digital result delivery, ensuring confidentiality and integrity of health data.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Defines the standards of care for invasive diagnostic procedures, patient consent requirements, and professional accountability in clinical genetics practice.
All laboratory processes are ISO 9001:2015 certified, and clinical staff hold current DHA licensure. Patients have the right to access their data, request corrections, and withdraw consent for secondary use in accordance with applicable regulations.
Clinical & Logistical Metadata
| Test Name | Microarray 750K+ Single Karyotyping |
| Price (AED) | AED 3,600 |
| Turnaround Time | 7–9 Business Days |
| Sample Type / Matrix | Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Affymetrix CytoScan 750K Array + Cell Culture |
| ICD-10-CM Code | Z13.89, O35.1XX0, N96 |
| LOINC Code | 82167-0 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians